Annual report
6856.TEDINET S100VIZI
Period2024-01-01 → 2024-12-31
Filed2025-03-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥317.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥290.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥187.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥48.3bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥47.3bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥50.2bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥48.3bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.4bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥48.8bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥53.7bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥33.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥13.2bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥33.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥481.6bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥449.0bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥371.6bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥328.1bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥166.9bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥165.3bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥314.7bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥283.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31d | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥178.7bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥144.3bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥132.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥144.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥130.6bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥138.8bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥40.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.0bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.3bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥17.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.3bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥15.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥21.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥22.4bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥843m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥799.44 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥953.71 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥312.58 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥795.34 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥948.83 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥311.09 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥7,485.06 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥6,695.3 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,684.68 | at 2022-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,827.06 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,217.45 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 65.2% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.3% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.4% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.4% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 8,955 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 8,665 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 8,432 | at 2022-12-31d | Cons. | Number of employees |
| Employees | 8,205 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 8,269 | at 2020-12-31d | Cons. | Number of employees |
| Revenue | ¥60.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥54.6bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥51.9bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥50.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥50.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥6.1bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥5.2bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥22.8bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥24.0bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥16.0bn | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.7bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.2bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.4bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥23.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥13.6bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥22.7bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥14.6bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥215.5bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥224.6bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥223.0bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥221.8bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥214.2bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥84.8bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥90.5bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥130.7bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥134.1bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥119.7bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥113.2bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥114.7bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥41.4bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥37.8bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥324.3 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥537.92 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥344.94 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.03 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.02 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥322.63 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥535.17 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥343.16 | 2022-01-01 → 2022-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.8 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥171.2 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥270 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥290 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥245 | 2022-01-01 → 2022-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,099.51 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,156.37 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,815.8 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,664.43 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,700.73 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 60.3% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.4% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.3% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.3% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.0% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.6% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 42,233,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,532,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,546 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 1,510 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 1,484 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 1,542 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 1,623 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 72
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥163.6bn |
| Automotive Test Systemsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥5.3bn |
| Automotive Test Systemsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥4.8bn |
| Automotive Test Systemsreportable segment | employees | at 2024-12-31 | 2744 pure |
| Automotive Test Systemsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥93.5bn |
| Automotive Test Systemsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥93.5bn |
| Automotive Test Systemsreportable segment | segment assets | at 2024-12-31 | ¥112.9bn |
| Automotive Test Systemsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥1.5bn |
| Medical Diagnostic Instruments And Systemsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥1.6bn |
| Medical Diagnostic Instruments And Systemsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥2.0bn |
| Medical Diagnostic Instruments And Systemsreportable segment | employees | at 2024-12-31 | 1158 pure |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥33.7bn |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥33.7bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment assets | at 2024-12-31 | ¥30.4bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥150m |
| Process And Environmental Instruments And Systemsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥718m |
| Process And Environmental Instruments And Systemsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥848m |
| Process And Environmental Instruments And Systemsreportable segment | employees | at 2024-12-31 | 674 pure |
| Process And Environmental Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥28.2bn |
| Process And Environmental Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥28.2bn |
| Process And Environmental Instruments And Systemsreportable segment | segment assets | at 2024-12-31 | ¥24.0bn |
| Process And Environmental Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥1.8bn |
| Scientific Instruments And Systemsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| Scientific Instruments And Systemsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥1.5bn |
| Scientific Instruments And Systemsreportable segment | employees | at 2024-12-31 | 1094 pure |
| Scientific Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥41.5bn |
| Scientific Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥41.5bn |
| Scientific Instruments And Systemsreportable segment | segment assets | at 2024-12-31 | ¥35.2bn |
| Scientific Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥982m |
| Semiconductor Instruments And Systemsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥10.6bn |
| Semiconductor Instruments And Systemsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥3.5bn |
| Semiconductor Instruments And Systemsreportable segment | employees | at 2024-12-31 | 1432 pure |
| Semiconductor Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥120.5bn |
| Semiconductor Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥120.5bn |
| Semiconductor Instruments And Systemsreportable segment | segment assets | at 2024-12-31 | ¥115.5bn |
| Semiconductor Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥44.2bn |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥151.3bn |
| Automotive Test Systemsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥4.1bn |
| Automotive Test Systemsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥4.5bn |
| Automotive Test Systemsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥80.4bn |
| Automotive Test Systemsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥80.4bn |
| Automotive Test Systemsreportable segment | segment assets | at 2023-12-31 | ¥103.8bn |
| Automotive Test Systemsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Medical Diagnostic Instruments And Systemsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Medical Diagnostic Instruments And Systemsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥2.1bn |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥32.7bn |
| Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥32.7bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment assets | at 2023-12-31 | ¥30.9bn |
| Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥638m |
| Process And Environmental Instruments And Systemsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥548m |
| Process And Environmental Instruments And Systemsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥819m |
| Process And Environmental Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥25.0bn |
| Process And Environmental Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥25.0bn |
| Process And Environmental Instruments And Systemsreportable segment | segment assets | at 2023-12-31 | ¥23.5bn |
| Process And Environmental Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.4bn |
| Scientific Instruments And Systemsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥986m |
| Scientific Instruments And Systemsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.5bn |
| Scientific Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥39.6bn |
| Scientific Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥39.6bn |
| Scientific Instruments And Systemsreportable segment | segment assets | at 2023-12-31 | ¥37.0bn |
| Scientific Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.5bn |
| Semiconductor Instruments And Systemsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥2.3bn |
| Semiconductor Instruments And Systemsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥3.2bn |
| Semiconductor Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥112.9bn |
| Semiconductor Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥112.9bn |
| Semiconductor Instruments And Systemsreportable segment | segment assets | at 2023-12-31 | ¥102.5bn |
| Semiconductor Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥40.6bn |
| Automotive Test Systemsreportable segment | employees | at 2024-12-31 | 374 pure |
| Medical Diagnostic Instruments And Systemsreportable segment | employees | at 2024-12-31 | 144 pure |
| Process And Environmental Instruments And Systemsreportable segment | employees | at 2024-12-31 | 153 pure |
| Scientific Instruments And Systemsreportable segment | employees | at 2024-12-31 | 131 pure |
| Semiconductor Instruments And Systemsreportable segment | employees | at 2024-12-31 | 43 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,874
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 214207000000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 221751000000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 223047000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 224577000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 215499000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 2700.73 | |
| Net assets per share (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 2664.43 | |
| Net assets per share (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 2815.80 | |
| Net assets per share (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 3156.37 | |
| Net assets per share (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 3099.51 | |
| Dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 90.00 | |
| Dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 150.00 | |
| Dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 245.00 | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 290.00 | |
| Dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 270.00 | |
| Interim dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 30.00 | |
| Interim dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 50.00 | |
| Interim dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 65.00 | |
| Interim dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 80.00 | |
| Interim dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 80.00 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 172.02 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 45.03 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 344.94 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 537.92 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 324.30 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 171.20 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 44.80 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 343.16 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 535.17 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 322.63 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 0.5320 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 0.5070 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 0.5331 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.5941 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.6034 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.0644 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.0168 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.1259 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.1802 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.1034 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 35.17 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 150.12 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 16.61 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 20.50 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 28.22 | |
| Payout ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.5232 | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 3.3310 | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.7105 | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.5393 | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.8326 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |